Cargando…

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti-RSV fusion (F) protein monoclonal antibody (mAb). While anti-F protein mAbs neutralize RSV, they are unable to pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergeron, Harrison C., Murray, Jackelyn, Arora, Aakash, Nuñez Castrejon, Ana M., DuBois, Rebecca M., Anderson, Larry J., Kauvar, Lawrence M., Tripp, Ralph A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221658/ https://www.ncbi.nlm.nih.gov/pubmed/37243153 http://dx.doi.org/10.3390/v15051067

Ejemplares similares

Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies
por: Bergeron, Harrison C., et al.
Publicado: (2021)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
por: Murray, Jackelyn, et al.
Publicado: (2022)

Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens
por: Nuñez Castrejon, Ana M., et al.
Publicado: (2022)

Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
por: Bergeron, Harrison C., et al.
Publicado: (2023)

Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response
por: Bergeron, Harrison C., et al.
Publicado: (2023)

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
por: Hijano, Diego R., et al.
Publicado: (2019)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Immunopathology of RSV: An Updated Review
por: Bergeron, Harrison C., et al.
Publicado: (2021)

Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis
por: Tripp, Ralph A.
Publicado: (2013)

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015)

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
por: Bakre, Abhijeet A., et al.
Publicado: (2017)

Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
por: Whelan, Barbara, et al.
Publicado: (2016)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

Respiratory Syncytial Virus (RSV)
por: Walsh, Edward E., et al.
Publicado: (2015)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
por: Tripp, Ralph A., et al.
Publicado: (2022)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
por: Atherton, Lydia J., et al.
Publicado: (2019)

Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication
por: Mathew, Cynthia, et al.
Publicado: (2021)

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
por: Bentley, Anthony, et al.
Publicado: (2013)

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
por: Maas, Brian M., et al.
Publicado: (2021)

Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
por: Jorquera, Patricia A., et al.
Publicado: (2013)

Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013)

Impact of COVID-19 Pandemic on Respiratory Syncytial Virus (RSV) Prophylaxis Program: A Tertiary-Care Center Experience
por: Kelabi, Hamza M, et al.
Publicado: (2023)

Predictors of disease severity are similar for respiratory syncytial virus (RSV)-positive and RSV-negative induced respiratory failure
por: Davis, E, et al.
Publicado: (2004)

Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV
por: Derscheid, Rachel J., et al.
Publicado: (2013)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)
por: Mahikul, Wiriya, et al.
Publicado: (2019)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
por: Gatt, Dvir, et al.
Publicado: (2023)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis
por: Chee, Chris, et al.
Publicado: (2010)

Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis
por: Jacque, Emilie, et al.
Publicado: (2021)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
por: Paes, B., et al.
Publicado: (2012)

Epidemiological Changes of Respiratory Syncytial Virus (RSV) Infections in Israel
por: Hirsh, Shira, et al.
Publicado: (2014)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
por: Derscheid, Rachel J., et al.
Publicado: (2012)

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis
por: Pickles, Raymond J, et al.
Publicado: (2015)

Detection of respiratory syncytial virus (RSV) at birth in a newborn with respiratory distress
por: Manti, Sara, et al.
Publicado: (2017)

Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes
por: McLaurin, Kimmie K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2frlg3hgs0488lij9fd90o6o4j